Free Trial

Vir Biotechnology (VIR) Insider Trading & Ownership

$7.58
-0.14 (-1.81%)
(As of 01:58 PM ET)

Vir Biotechnology (NASDAQ:VIR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
15.60%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$1.66 M
Get VIR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vir Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VIR Insider Buying and Selling by Quarter

Vir Biotechnology Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/9/2024Janet NapolitanoDirectorSell12,190$7.80$95,082.00  
6/11/2024Saira RamasastryDirectorSell4,000$10.95$43,800.00  
4/3/2024Backer Marianne DeCEOSell72,995$9.46$690,532.70  
4/1/2024Ann M HanlyEVPSell2,711$10.05$27,245.55  
3/27/2024Sung LeeCFOSell6,008$9.89$59,419.12  
2/26/2024George A ScangosDirectorSell17,722$11.65$206,461.30  
Crypto’s next big bull run? (Ad)

Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on November 5. Just a day after the American election, Juan believes crypto could start a massive run up …

And one special coin could do even better.
2/22/2024Ann M HanlyEVPSell12,296$10.05$123,574.80  
2/22/2024George A ScangosDirectorSell10,028$10.05$100,781.40  
2/20/2024George A ScangosDirectorSell16,872$10.22$172,431.84  
2/16/2024George A ScangosDirectorSell10,878$10.24$111,390.72  
2/16/2024Phillip PangEVPSell3,321$10.24$34,007.04  
(Data available from 1/1/2013 forward)

VIR Insider Trading Activity - Frequently Asked Questions

The list of insiders at Vir Biotechnology includes Ann M Hanly, Backer Marianne De, Charles Elliott Sigal, Endurance (Cayman) Ltd Svf, George A Scangos, Herbert Virgin, Howard Horn, Janet Napolitano, Johanna Friedl-Naderer, Phillip Pang, Saira Ramasastry, Steven J Rice, Sung Lee, and Vicki L Sato. Learn more on insiders at VIR.

15.60% of Vir Biotechnology stock is owned by insiders. Learn more on VIR's insider holdings.

The following insider purchased VIR shares in the last 24 months: Charles Elliott Sigal ($126,400.00).

Insiders have purchased a total of 5,000 VIR shares in the last 24 months for a total of $126,400.00 bought.

The following insiders have sold VIR shares in the last 24 months: Ann M Hanly ($270,420.08), Backer Marianne De ($690,532.70), Endurance (Cayman) Ltd Svf ($78,577,345.09), George A Scangos ($1,674,636.39), Howard Horn ($119,683.52), Janet Napolitano ($95,082.00), Johanna Friedl-Naderer ($33,819.24), Phillip Pang ($1,138,498.70), Saira Ramasastry ($133,645.00), Steven J Rice ($114,274.49), Sung Lee ($59,419.12), and Vicki L Sato ($2,310,716.50).

Insiders have sold a total of 3,294,631 Vir Biotechnology shares in the last 24 months for a total of $85,218,072.83 sold.

Vir Biotechnology Key Executives

  • Dr. Marianne De Backer M.B.A. (Age 55)
    M.Sc., Ph.D., CEO & Director
    Compensation: $4.47M
  • Dr. Ann M. Hanly Ph.D. (Age 54)
    Executive VP & Chief Technology Officer
    Compensation: $896.07k
  • Dr. Jeff Calcagno M.D. (Age 63)
    Executive VP & Chief Business Officer
    Compensation: $860.49k
  • Dr. Klaus Frueh Ph.D. (Age 64)
    Co-Founder & Scientific Advisor
    Compensation: $177.66k
  • Dr. Lawrence Corey M.D. (Age 77)
    Co-Founder & Scientific Advisor
  • Dr. Louis J. Picker M.D.
    Co-Founder & Scientific Advisor
  • Dr. Jennifer Eileen Towne Ph.D.
    Executive VP & Chief Scientific Officer
  • Ms. Heather Rowe Armstrong
    Vice President of Investor Relations
  • Ms. Vanina De Verneuil J.D.
    Executive VP, General Counsel & Corporate Secretary
  • Ms. Arran Attridge
    Senior Vice President of Corporate Communications


This page (NASDAQ:VIR) was last updated on 10/18/2024 by MarketBeat.com Staff
From Our Partners